Table 1.
Set of investment opportunities. This table reports the assets considered as a potential pool of investment opportunities. This spectrum of assets is broken down into three panels differentiating between the financial sector, the healthcare sector and the pharmaceutical sector (Panels A, B and C, respectively). By columns, the ticker or identifier of each ETF, the denomination, and the market cap of the ETFs as of the date of the study (April 2021) are shown.
| Ticker | Exchange Traded Fund (ETF) | Market cap ($MM) |
|---|---|---|
| Panel A: financial sector | ||
| XLF | Financial Select Sector SPDR Fund | 44,500.20 |
| VFH | Vanguard Financials | 10,955.10 |
| KRE | SPDR S&P Regional Banking | 5,276.72 |
| KBE | SPDR S&P Bank | 3,545,74 |
| FAS | Direxion Daily Financial Bull 3X Shares | 3,404.33 |
| KBWB | Invesco KBW Bank | 2,656.13 |
| IYF | iShares U.S. Financials | 2,456.56 |
| Panel B: healthcare sector | ||
| XLV | Health Care Select Sector SPDR Fund | 27,840.90 |
| VHT | Vanguard Health Care | 14,860.20 |
| IBB | iShares Nasdaq Biotechnology | 10,956.50 |
| ARKG | ARK Genomic Revolution | 8,910.70 |
| XBI | SPDR S&P Biotech | 7,485.38 |
| IHI | iShares U.S. Medical Devices | 7,446.87 |
| IXJ | iShares Global Healthcare | 3,103.29 |
| Panel C: pharmaceutical sector | ||
| PJP | Invesco Dynamic Pharmaceuticals | 372.37 |
| IHE | iShares U.S. Pharmaceuticals | 375.76 |
| XPH | SPDR S&P Pharmaceuticals | 272.56 |
| PPH | VanEck Vectors Pharmaceutical | 241.03 |
| KURE | KraneShares MSCI All China Health Care Index | 250.58 |
| CHIH | Global X MSCI China Health Care | 21.66 |
| FTXH | First Trust Nasdaq Pharmaceuticals | 22.40 |